It has been recently identified that ALL patients with up-regulated proto-oncogene Bmi-1 at the time of diagnosis, show lower RFS rate (75.8%) than patients with down-regulated expression level of Bmi-1 (94.1%). The gene discussed is BMI1; the disease is acute lymphoblastic leukemia.